- Home
- KOSS vs MAIA Comparison
KOSS vs MAIA Comparison
Compare KOSS & MAIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KOSS
- MAIA
- Stock Information
- Founded
- KOSS 1953
- MAIA 2018
- Country
- KOSS United States
- MAIA United States
- Employees
- KOSS N/A
- MAIA N/A
- Industry
- KOSS Consumer Electronics/Appliances
- MAIA Biotechnology: Pharmaceutical Preparations
- Sector
- KOSS Consumer Staples
- MAIA Health Care
- Exchange
- KOSS Nasdaq
- MAIA Nasdaq
- Market Cap
- KOSS 63.0M
- MAIA 62.4M
- IPO Year
- KOSS N/A
- MAIA 2022
- Fundamental
- Price
- KOSS $8.32
- MAIA $2.52
- Analyst Decision
- KOSS
- MAIA
- Analyst Count
- KOSS 0
- MAIA 0
- Target Price
- KOSS N/A
- MAIA N/A
- AVG Volume (30 Days)
- KOSS 228.2K
- MAIA 69.2K
- Earning Date
- KOSS 10-24-2024
- MAIA 11-05-2024
- Dividend Yield
- KOSS N/A
- MAIA N/A
- EPS Growth
- KOSS N/A
- MAIA N/A
- EPS
- KOSS N/A
- MAIA N/A
- Revenue
- KOSS $12,265,069.00
- MAIA N/A
- Revenue This Year
- KOSS N/A
- MAIA N/A
- Revenue Next Year
- KOSS N/A
- MAIA N/A
- P/E Ratio
- KOSS N/A
- MAIA N/A
- Revenue Growth
- KOSS N/A
- MAIA N/A
- 52 Week Low
- KOSS $2.27
- MAIA $0.82
- 52 Week High
- KOSS $18.73
- MAIA $5.99
- Technical
- Relative Strength Index (RSI)
- KOSS 67.73
- MAIA 40.72
- Support Level
- KOSS $6.88
- MAIA $2.25
- Resistance Level
- KOSS $8.50
- MAIA $2.85
- Average True Range (ATR)
- KOSS 0.42
- MAIA 0.21
- MACD
- KOSS 0.17
- MAIA -0.00
- Stochastic Oscillator
- KOSS 90.00
- MAIA 41.73
About KOSS Koss Corporation
Koss Corp is engaged in the design, manufacture, and sale of stereo headphones and related accessory products. It operates in the audio/video industry segment of the home entertainment industry. The company markets a line of headphones, wireless Bluetooth headphones, wireless Bluetooth speakers, computer headsets, telecommunications headsets, and active noise-cancelling headphones. The majority of the firm's revenue is derived from sales of stereo headphones.
About MAIA MAIA Biotechnology Inc.
MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company. The company develops targeted immunotherapies for cancer. The company is an immune-oncology company, focused on the development of first-in-class drugs with novel mechanisms of action that are intended to meaningfully improve and extend the lives of people with cancer. The company's program is THIO, a potential cancer telomere-targeting agent in clinical development for the treatment of telomerase-positive cancer cells.